Scholarlink

Biomaterials are biodegradable, biocompatible, and bioinert and mimic the extracellular matrix of the cell. This chapter discusses the current challenges in neuroprotective agents and the advantages of various biomaterials and their applications as neuroprotective agents. Natural and synthetic biomaterials mimic the ECM of the brain and aid drug and cell delivery. Biomaterials are widely used as carriers for the delivery of drugs and other biological substances particularly into the brain. Doping of drugs with biomaterials enhanced their bioavailability, permeability, safety, efficacy, and reduced toxicity and exhibited neuroprotection against AD, PD, stroke, SCI, TBI, ALS, etc. This chapter further addresses biomaterials and their loaded drugs-mediated improvement in neuroprotection by modulating oxidative stress, mitochondrial dysfunction, excitotoxicity, inflammation, and apoptosis. Furthermore, challenges in using biomaterials as a carrier for drug and cell delivery are also discussed in the present chapter. In conclusion, to improve the neuroprotective potential of biomaterials, continued multidisciplinary collaboration and translational research efforts are essential.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Advanced Biomaterials in Neuroprotection: Innovations and Clinical Applications

  • 章节

  • 发表日期：

    2025年

查看全文
  • Kakarla Ramakrishna,
  • Matte Kasi Viswanadh,
  • Naresh Dumala,
  • Guntupalli Chakravarth,
  • Kojja Venkateswarlu,
  • Gopichand Gutti,
  • Ganesh Yadagiri,
  • Sajusha Duguluri,
  • Sachchida Nand Rai

摘要

Biomaterials are biodegradable, biocompatible, and bioinert and mimic the extracellular matrix of the cell. This chapter discusses the current challenges in neuroprotective agents and the advantages of various biomaterials and their applications as neuroprotective agents. Natural and synthetic biomaterials mimic the ECM of the brain and aid drug and cell delivery. Biomaterials are widely used as carriers for the delivery of drugs and other biological substances particularly into the brain. Doping of drugs with biomaterials enhanced their bioavailability, permeability, safety, efficacy, and reduced toxicity and exhibited neuroprotection against AD, PD, stroke, SCI, TBI, ALS, etc. This chapter further addresses biomaterials and their loaded drugs-mediated improvement in neuroprotection by modulating oxidative stress, mitochondrial dysfunction, excitotoxicity, inflammation, and apoptosis. Furthermore, challenges in using biomaterials as a carrier for drug and cell delivery are also discussed in the present chapter. In conclusion, to improve the neuroprotective potential of biomaterials, continued multidisciplinary collaboration and translational research efforts are essential.